Hims & Hers Shares Fall as GLP-1 Costs Widen Q2 Loss

Hims Hers Health shares dropped more than 6% in after-hours trading after the telehealth company reported a wider-than-expected second-quarter loss, as rising costs tied to branded GLP-1 weight-loss drugs pressured...